NKMAX Co., Ltd.
Develops NK cell-based therapies, diagnostics, and biological products.
182400 | KO
Overview
Corporate Details
- ISIN(s):
- KR7182400002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 돌마로 172 정자동, 헬스케어혁신파크 1층및6층, 성남시
- Website:
- https://nkmax.com/
- Sector:
- Manufacturing
Description
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-17 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 32.6 KB | ||
| 2025-09-04 00:00 |
회생절차종결결정
|
Korean | 8.5 KB | ||
| 2025-09-03 00:00 |
기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내 )
|
Korean | 3.2 KB | ||
| 2025-08-25 00:00 |
회생절차종결신청
|
Korean | 12.4 KB | ||
| 2025-08-14 00:00 |
대표이사변경
|
Korean | 10.4 KB | ||
| 2025-08-14 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 13.7 KB | ||
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-08-14 00:00 |
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
|
Korean | 13.6 KB | ||
| 2025-08-13 00:00 |
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
|
Korean | 3.1 KB | ||
| 2025-08-12 00:00 |
[기재정정]감사보고서제출 (2024사업연도)
|
Korean | 45.4 KB | ||
| 2025-08-12 00:00 |
[기재정정]감사보고서제출 (2023사업연도)
|
Korean | 29.1 KB | ||
| 2025-08-12 00:00 |
기타주요경영사항 (자본전액잠식등 사유 해소자료 제출)
|
Korean | 3.6 KB | ||
| 2025-08-12 00:00 |
[기재정정]사업보고서 (2024.12)
|
Korean | 1.9 MB | ||
| 2025-08-12 00:00 |
기타시장안내 (감사의견 관련 형식적 상장폐지 사유 해소 및 매매거래정지 지속 안내)
|
Korean | 7.0 KB | ||
| 2025-08-12 00:00 |
주권매매거래정지기간변경 (상장폐지 사유 해소)
|
Korean | 5.0 KB |
Automate Your Workflow. Get a real-time feed of all NKMAX Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NKMAX Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NKMAX Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
